Please login to the form below

Not currently logged in
Email:
Password:

Dr Susanne Fiedler takes over as CEO of MSD Germany

Hanspeter Quodt steps down after seven years in the post

MSD Dr Susanne FiedlerMSD Germany has appointed Dr Susanne Fiedler as CEO to take over from Hanspeter Quodt, who steps after seven years in the post.

Dr Fielder first joined the German operations of Merck & Co in 1997, when she took up a role in market research.

She then moved to market, initially as a product manager and later as a marketing manager and then a business unit head with responsibility for a number of MSD products.

Since then Dr Fielder has served in the US, where MSD operates at Merck & Co, as global brand leader for the diabetes treatments Januvia and Janumet, before taking up a Sydney-based role as managing director of MSD Australia and New Zealand.

She will officially take on her new role on 1 February, when Quodt moves to a new European level position.

27th January 2016

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hamell

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

Working together against COVID-19
Analysing social media conversations to see what HCPs are saying online about the global pandemic...
Vicky Bramham, Managing Director at OPEN Health PR shares tips on media relations during COVID-19
Vicky speaks with freelance health journalist Jacqui Thornton who gives her expert view on how best to approach media relations during this unprecedented time....
Are biobetters a market access opportunity?
Biobetters are biologics that have been improved compared to the marketed originator, for example in efficacy, safety, tolerability or dosing regimen....

Infographics